Lumateperone - Latest Advances

Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial.

Journal: The American journal of psychiatry

Published: December 01, 2025

Reply: Statistical limitations of the claimed dose-response in "Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials".

Journal: Journal of psychopharmacology (Oxford, England)

Published: November 27, 2025

Statistical limitations of the claimed dose-response in "Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials".

Journal: Journal of psychopharmacology (Oxford, England)

Published: November 27, 2025

Lumateperone Safety and Tolerability in Schizophrenia: A Narrative Review.

Journal: Cureus

Published: November 04, 2025

Efficacy of Lumateperone in Depression Associated With Bipolar II Disorder: A Pooled Analysis of Late-Phase Clinical Trials.

Journal: CNS spectrums

Published: September 29, 2025

Valbenazine for the Treatment of Chronic Motor or Vocal Tic Disorder (CMVTD).

Journal: Cureus

Published: September 19, 2025

Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial.

Journal: The Journal of clinical psychiatry

Published: August 28, 2025

Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials.

Journal: Journal of psychopharmacology (Oxford, England)

Published: August 28, 2025

Efficacy and Safety of Cariprazine, Asenapine, Xanomeline-Trospium, and Lumateperone for Acute Exacerbations of Schizophrenia in Adults: A Network Meta-Analysis.

Journal: Schizophrenia bulletin open

Published: August 21, 2025

Electroconvulsive Therapy for Treatment-Resistant Late-Onset Bipolar Disorder.

Journal: Cureus

Published: August 13, 2025

Volumetric absorptive microsampling for lumateperone analysis: method validation and stability evaluation.

Journal: Analytical and bioanalytical chemistry

Published: July 31, 2025

Lumateperone monotherapy for major depressive episodes associated with bipolar disorder: efficacy and safety in a randomized placebo-controlled trial.

Journal: International clinical psychopharmacology

Published: July 22, 2025

Filters

Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial.

Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial.

Reply: Statistical limitations of the claimed dose-response in "Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials".

Reply: Statistical limitations of the claimed dose-response in "Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials".

Statistical limitations of the claimed dose-response in "Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials".

Statistical limitations of the claimed dose-response in "Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials".

Lumateperone Safety and Tolerability in Schizophrenia: A Narrative Review.

Lumateperone Safety and Tolerability in Schizophrenia: A Narrative Review.

Efficacy of Lumateperone in Depression Associated With Bipolar II Disorder: A Pooled Analysis of Late-Phase Clinical Trials.

Efficacy of Lumateperone in Depression Associated With Bipolar II Disorder: A Pooled Analysis of Late-Phase Clinical Trials.

Valbenazine for the Treatment of Chronic Motor or Vocal Tic Disorder (CMVTD).

Valbenazine for the Treatment of Chronic Motor or Vocal Tic Disorder (CMVTD).

Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial.

Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial.

Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials.

Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials.

Efficacy and Safety of Cariprazine, Asenapine, Xanomeline-Trospium, and Lumateperone for Acute Exacerbations of Schizophrenia in Adults: A Network Meta-Analysis.

Efficacy and Safety of Cariprazine, Asenapine, Xanomeline-Trospium, and Lumateperone for Acute Exacerbations of Schizophrenia in Adults: A Network Meta-Analysis.

Electroconvulsive Therapy for Treatment-Resistant Late-Onset Bipolar Disorder.

Electroconvulsive Therapy for Treatment-Resistant Late-Onset Bipolar Disorder.

Volumetric absorptive microsampling for lumateperone analysis: method validation and stability evaluation.

Volumetric absorptive microsampling for lumateperone analysis: method validation and stability evaluation.

Lumateperone monotherapy for major depressive episodes associated with bipolar disorder: efficacy and safety in a randomized placebo-controlled trial.

Lumateperone monotherapy for major depressive episodes associated with bipolar disorder: efficacy and safety in a randomized placebo-controlled trial.